Simmunome AI ^Companies

Simmunome AI is an artificial intelligence-based contract research organization that specializes in developing industry-ready computational models of pathogenesis and immunogenesis of various diseases, with a focus on oncology and the nervous system. Their models are achieved by annotating cellular interactions at a molecular level to attain physiological accuracy. Simmunome creates accurate and comprehensive in silico disease models using multi-omic data to determine the probability of success of a drug. Their clinical trial simulations help de-risk pipelines, reduce R&D costs, and increase speed to market. By combining fragmented data, Simmunome creates holistic models of diseases that help understand a drug's mechanism of action, increase efficacy, and predict safety profiles.